Cargando…

Type 2 Diabetes in Xinjiang Uygur Autonomous Region, China

BACKGROUND: The aim of this study was to estimate the prevalence and distribution of type 2 diabetes and to determine the status of type 2 diabetes awareness, treatment, and control in Xinjiang, China. Our data came from the Cardiovascular Risk Survey (CRS) study designed to investigate the prevalen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yi-Ning, Xie, Xiang, Ma, Yi-Tong, Li, Xiao-Mei, Fu, Zhen-Yan, Ma, Xiang, Huang, Ding, Chen, Bang-Dang, Liu, Fen, Huang, Ying, Liu, Cheng, Zheng, Ying-Ying, Baituola, Gulinaer, YU, Zi-Xiang, Chen, You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323648/
https://www.ncbi.nlm.nih.gov/pubmed/22506076
http://dx.doi.org/10.1371/journal.pone.0035270
_version_ 1782229248622198784
author Yang, Yi-Ning
Xie, Xiang
Ma, Yi-Tong
Li, Xiao-Mei
Fu, Zhen-Yan
Ma, Xiang
Huang, Ding
Chen, Bang-Dang
Liu, Fen
Huang, Ying
Liu, Cheng
Zheng, Ying-Ying
Baituola, Gulinaer
YU, Zi-Xiang
Chen, You
author_facet Yang, Yi-Ning
Xie, Xiang
Ma, Yi-Tong
Li, Xiao-Mei
Fu, Zhen-Yan
Ma, Xiang
Huang, Ding
Chen, Bang-Dang
Liu, Fen
Huang, Ying
Liu, Cheng
Zheng, Ying-Ying
Baituola, Gulinaer
YU, Zi-Xiang
Chen, You
author_sort Yang, Yi-Ning
collection PubMed
description BACKGROUND: The aim of this study was to estimate the prevalence and distribution of type 2 diabetes and to determine the status of type 2 diabetes awareness, treatment, and control in Xinjiang, China. Our data came from the Cardiovascular Risk Survey (CRS) study designed to investigate the prevalence and risk factors for cardiovascular diseases in Xinjiang from October 2007 to March 2010. A total of 14 122 persons (5583 Hans, 4620 Uygurs, and 3919 Kazaks) completed the survey and examination. Diabetes was defined by the American Diabetes Association 2009 criteria. METHODOLOGY/PRINCIPAL FINDINGS: Overall, 9.26% of the Han, 6.23% of the Uygur, and 3.65% of the Kazak adults aged ≥35 years had diabetes. Among diabetes patients, only 53.0% were aware of their blood glucose level, 26.7% were taking hypoglycemic agents, and 10.4% achieved blood glucose control in Han, 35.8% were aware of their blood glucose level, 7.3% were taking hypoglycemic agents, and 3.13% achieved blood glucose control in Uygur, and 23.8% were aware of their blood glucose level, 6.3% were taking hypoglycemic agents, and 1.4% achieved blood glucose control in Kazak, respectively. CONCLUSIONS/SIGNIFICANCE: Our results indicate that diabetes is highly prevalent in Xinjiang. The percentages of those with diabetes who are aware, treated, and controlled are unacceptably low. These results underscore the urgent need to develop national strategies to improve prevention, detection, and treatment of diabetes in Xinjiang, the west China.
format Online
Article
Text
id pubmed-3323648
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33236482012-04-13 Type 2 Diabetes in Xinjiang Uygur Autonomous Region, China Yang, Yi-Ning Xie, Xiang Ma, Yi-Tong Li, Xiao-Mei Fu, Zhen-Yan Ma, Xiang Huang, Ding Chen, Bang-Dang Liu, Fen Huang, Ying Liu, Cheng Zheng, Ying-Ying Baituola, Gulinaer YU, Zi-Xiang Chen, You PLoS One Research Article BACKGROUND: The aim of this study was to estimate the prevalence and distribution of type 2 diabetes and to determine the status of type 2 diabetes awareness, treatment, and control in Xinjiang, China. Our data came from the Cardiovascular Risk Survey (CRS) study designed to investigate the prevalence and risk factors for cardiovascular diseases in Xinjiang from October 2007 to March 2010. A total of 14 122 persons (5583 Hans, 4620 Uygurs, and 3919 Kazaks) completed the survey and examination. Diabetes was defined by the American Diabetes Association 2009 criteria. METHODOLOGY/PRINCIPAL FINDINGS: Overall, 9.26% of the Han, 6.23% of the Uygur, and 3.65% of the Kazak adults aged ≥35 years had diabetes. Among diabetes patients, only 53.0% were aware of their blood glucose level, 26.7% were taking hypoglycemic agents, and 10.4% achieved blood glucose control in Han, 35.8% were aware of their blood glucose level, 7.3% were taking hypoglycemic agents, and 3.13% achieved blood glucose control in Uygur, and 23.8% were aware of their blood glucose level, 6.3% were taking hypoglycemic agents, and 1.4% achieved blood glucose control in Kazak, respectively. CONCLUSIONS/SIGNIFICANCE: Our results indicate that diabetes is highly prevalent in Xinjiang. The percentages of those with diabetes who are aware, treated, and controlled are unacceptably low. These results underscore the urgent need to develop national strategies to improve prevention, detection, and treatment of diabetes in Xinjiang, the west China. Public Library of Science 2012-04-10 /pmc/articles/PMC3323648/ /pubmed/22506076 http://dx.doi.org/10.1371/journal.pone.0035270 Text en Yang et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Yang, Yi-Ning
Xie, Xiang
Ma, Yi-Tong
Li, Xiao-Mei
Fu, Zhen-Yan
Ma, Xiang
Huang, Ding
Chen, Bang-Dang
Liu, Fen
Huang, Ying
Liu, Cheng
Zheng, Ying-Ying
Baituola, Gulinaer
YU, Zi-Xiang
Chen, You
Type 2 Diabetes in Xinjiang Uygur Autonomous Region, China
title Type 2 Diabetes in Xinjiang Uygur Autonomous Region, China
title_full Type 2 Diabetes in Xinjiang Uygur Autonomous Region, China
title_fullStr Type 2 Diabetes in Xinjiang Uygur Autonomous Region, China
title_full_unstemmed Type 2 Diabetes in Xinjiang Uygur Autonomous Region, China
title_short Type 2 Diabetes in Xinjiang Uygur Autonomous Region, China
title_sort type 2 diabetes in xinjiang uygur autonomous region, china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323648/
https://www.ncbi.nlm.nih.gov/pubmed/22506076
http://dx.doi.org/10.1371/journal.pone.0035270
work_keys_str_mv AT yangyining type2diabetesinxinjianguygurautonomousregionchina
AT xiexiang type2diabetesinxinjianguygurautonomousregionchina
AT mayitong type2diabetesinxinjianguygurautonomousregionchina
AT lixiaomei type2diabetesinxinjianguygurautonomousregionchina
AT fuzhenyan type2diabetesinxinjianguygurautonomousregionchina
AT maxiang type2diabetesinxinjianguygurautonomousregionchina
AT huangding type2diabetesinxinjianguygurautonomousregionchina
AT chenbangdang type2diabetesinxinjianguygurautonomousregionchina
AT liufen type2diabetesinxinjianguygurautonomousregionchina
AT huangying type2diabetesinxinjianguygurautonomousregionchina
AT liucheng type2diabetesinxinjianguygurautonomousregionchina
AT zhengyingying type2diabetesinxinjianguygurautonomousregionchina
AT baituolagulinaer type2diabetesinxinjianguygurautonomousregionchina
AT yuzixiang type2diabetesinxinjianguygurautonomousregionchina
AT chenyou type2diabetesinxinjianguygurautonomousregionchina